Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
7
|
| gptkbp:bfsParent |
gptkb:Dexlansoprazole
|
| gptkbp:activities |
inhibits proton pump in gastric parietal cells
|
| gptkbp:approves |
gptkb:U._S._Food_and_Drug_Administration_(FDA)
|
| gptkbp:availability |
available in many countries
|
| gptkbp:brand |
gptkb:Dexilant
|
| gptkbp:category |
gptkb:unknown
Category B |
| gptkbp:class |
gptkb:railway_station
|
| gptkbp:clinical_trial |
Phase III
|
| gptkbp:contraindication |
hypersensitivity to dexlansoprazole
|
| gptkbp:dosage_form |
30 mg capsule
60 mg capsule |
| gptkbp:form |
gptkb:beer
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dexilant
|
| gptkbp:ingredients |
dexlansoprazole
|
| gptkbp:interacts_with |
may interact with warfarin
may interact with clopidogrel may interact with methotrexate |
| gptkbp:is_used_for |
treatment of gastroesophageal reflux disease (GERD)
|
| gptkbp:lifespan |
approximately 5 to 8 hours
|
| gptkbp:manager |
oral
|
| gptkbp:manufacturer |
gptkb:Takeda_Pharmaceutical_Company
|
| gptkbp:marketed_as |
gptkb:2010
|
| gptkbp:packaging |
blister pack
|
| gptkbp:population |
can be taken with or without food
do not crush or chew capsules take at least 30 minutes before a meal |
| gptkbp:previous_name |
dexlansoprazole
|
| gptkbp:price |
varies by location and insurance
|
| gptkbp:products |
gptkb:lansoprazole
gptkb:omeprazole gptkb:pantoprazole rabeprazole |
| gptkbp:requires |
prescription only
|
| gptkbp:rounds |
primarily through urine
|
| gptkbp:side_effect |
headache
nausea abdominal pain vomiting diarrhea risk of bone fractures risk of Clostridium difficile infection risk of kidney problems risk of low magnesium levels |
| gptkbp:storage |
store at room temperature
|